Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease

    • Blood Disorder
    • Blood platelet disorder
    • Von Willebrand disease (VWD)